HomeTENX • NASDAQ
add
Tenax Therapeutics Inc
Previous close
$14.19
Day range
$13.70 - $14.85
Year range
$4.64 - $18.38
Market cap
236.30M USD
Avg Volume
293.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.45M | 125.48% |
Net income | -15.54M | -147.97% |
Net profit margin | — | — |
Earnings per share | -0.38 | -111.11% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.56M | 2.86% |
Total assets | 104.23M | 7.80% |
Total liabilities | 7.16M | 52.48% |
Total equity | 97.07M | — |
Shares outstanding | 50.30M | — |
Price to book | 6.20 | — |
Return on assets | -39.72% | — |
Return on capital | -42.55% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.54M | -147.97% |
Cash from operations | -13.42M | -280.35% |
Cash from investing | — | — |
Cash from financing | 11.61M | 17,229.85% |
Net change in cash | -1.80M | 47.86% |
Free cash flow | -8.15M | -347.97% |
About
Founded
1967
Website
Employees
14
